{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:04:58Z","timestamp":1790759098061,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dutch Anti-Doping Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Androgen abuse has been suggested to adversely affect sleep-disordered breathing, but prospective real-world data in androgen abusers are lacking. The aim of this study was to evaluate the effects of androgen abuse on sleep-disordered breathing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult men planning a self-initiated androgen cycle were evaluated before, at approximately week 8 of their cycle, and approximately three months after cycle cessation. Sleep was assessed using ambulatory WatchPAT monitoring. The primary outcome was change in the peripheral arterial tone\u2013derived apnea\u2013hypopnea index (pAHI). Secondary outcomes included peripheral arterial tone-derived respiratory distress index (pRDI) and oxygen desaturation index (pODI), sleep architecture and subjective sleep questionnaires as measured through the Epworth Sleepiness Scale (ESS) and Insomnia Severity Index (ISI). Longitudinal changes were analyzed using linear mixed-effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-three participants were included. Median cycle duration was 12\u00a0weeks with a median weekly dose of 678\u00a0mg. During the androgen cycle, pAHI did not increase significantly, whereas pRDI did increase (mean increase of 3.0 events\/hour). At post-cycle follow-up, pAHI, pRDI, and pODI were significantly increased compared with baseline (mean increases of 2.7, 4.4, and 3.0 events\/hour, respectively). Sleep architecture was largely preserved, although a modest reduction in deep sleep and an increase in heart rate was observed during androgen abuse. No significant changes were observed in total ESS or ISI scores across time points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings suggest that androgen abuse may exert subtle effects on sleep-disordered breathing parameters but are unlikely to translate into overt or clinically meaningful sleep apnea in most androgen abusers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration number<\/jats:title>\n                    <jats:p>Registration number P2117, study number NL77191.028.21.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-026-02943-y","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:41:05Z","timestamp":1784526065000},"page":"2785-2793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of androgen abuse on sleep apnea in men: a prospective cohort study"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9935-5968","authenticated-orcid":false,"given":"Tijs Johannes","family":"Verdegaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wout","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwin","family":"Machiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"de Ronde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik Laurens","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"2943_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","volume":"24","author":"D Sagoe","year":"2014","unstructured":"Sagoe D, Molde H, Andreassen C, Torsheim T, Pallesen S (2014) The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol 24:383\u2013398. https:\/\/doi.org\/10.1016\/j.annepidem.2014.01.009","journal-title":"Ann Epidemiol"},{"key":"2943_CR2","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1210\/jc.2018-01882","volume":"104","author":"B Anawalt","year":"2019","unstructured":"Anawalt B (2019) Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab 104:2490\u20132500. https:\/\/doi.org\/10.1210\/jc.2018-01882","journal-title":"J Clin Endocrinol Metab"},{"key":"2943_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2021.732318","author":"D Smit","year":"2021","unstructured":"Smit D, Voogel A, den Heijer M, de Ronde W (2021) Anabolic androgenic steroids induce reversible left ventricular hypertrophy and cardiac dysfunction. Echocardiography results of the HAARLEM study. Front Reprod Health. https:\/\/doi.org\/10.3389\/frph.2021.732318","journal-title":"Front Reprod Health"},{"key":"2943_CR4","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/humrep\/deaa366","volume":"36","author":"D Smit","year":"2021","unstructured":"Smit D, Buijs M, de Hon O, den Heijer M, de Ronde W (2021) Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study. Hum Reprod 36:880\u2013890. https:\/\/doi.org\/10.1093\/humrep\/deaa366","journal-title":"Hum Reprod"},{"key":"2943_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2022.1059473","volume":"13","author":"P Bond","year":"2022","unstructured":"Bond P, Smit DL, de Ronde P (2022) Anabolic-androgenic steroids: how do they work and what are the risks? Front Endocrinol 13:1\u201325. https:\/\/doi.org\/10.3389\/fendo.2022.1059473","journal-title":"Front Endocrinol"},{"issue":"6","key":"2943_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1080\/10826084.2025.2460986","volume":"60","author":"L Mingxing","year":"2025","unstructured":"Mingxing L, Yanfei Y (2025) Adverse effects of anabolic androgenic steroid abuse in athletes and physically active individuals: a systematic review and meta-analysis. Subst Use Misuse 60(6):873\u2013887. https:\/\/doi.org\/10.1080\/10826084.2025.2460986","journal-title":"Subst Use Misuse"},{"issue":"6","key":"2943_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-2265.1985.tb00161.x","volume":"22","author":"AM Matsumoto","year":"1985","unstructured":"Matsumoto AM, Sandblom RE, Schoene RB, Lee KA, Giblin EC, Pierson DJ, Bremner WJ (1985) Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives and sleep. Clin Endocrinol 22(6):713\u2013721. https:\/\/doi.org\/10.1111\/j.1365-2265.1985.tb00161.x","journal-title":"Clin Endocrinol"},{"issue":"9","key":"2943_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1056\/NEJM198303033080908","volume":"308","author":"RE Sandblom","year":"1983","unstructured":"Sandblom RE, Matsumoto AM, Schoene RB, Lee KA, Giblin EC, Bremner WJ, Pierson DJ (1983) Obstructive sleep apnea syndrome induced by testosterone administration. N Engl J Med 308(9):508\u2013510. https:\/\/doi.org\/10.1056\/NEJM198303033080908","journal-title":"N Engl J Med"},{"issue":"2","key":"2943_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1152\/jappl.1986.61.2.618","volume":"61","author":"BK Schneider","year":"1986","unstructured":"Schneider BK, Pickett CK, Zwillich CW, Weil JV, McDermott MT, Santen RJ, Varano LA, White DP (1986) Influence of testosterone on breathing during sleep. J Appl Physiol 61(2):618\u2013623. https:\/\/doi.org\/10.1152\/jappl.1986.61.2.618","journal-title":"J Appl Physiol"},{"issue":"8","key":"2943_CR10","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1210\/jc.2003-030236","volume":"88","author":"PY Liu","year":"2003","unstructured":"Liu PY, Yee B, Wishart SM, Jimenez M, Jung DG, Grunstein RR, Handelsman DJ (2003) The short-term effects of high-dose testosterone on sleep, breathing and function in older men. J Clin Endocrinol Metab 88(8):3605\u20133613. https:\/\/doi.org\/10.1210\/jc.2003-030236","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2943_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.sxmr.2020.04.004","volume":"9","author":"K Payne","year":"2021","unstructured":"Payne K, Lipshultz LI, Hotaling JM, Pastuszak AW (2021) Obstructive sleep apnea and testosterone therapy. Sexual Med Rev 9(2):296\u2013303. https:\/\/doi.org\/10.1016\/j.sxmr.2020.04.004","journal-title":"Sexual Med Rev"},{"issue":"8","key":"2943_CR12","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3978\/j.issn.2072-1439.2015.06.11","volume":"7","author":"KA Franklin","year":"2015","unstructured":"Franklin KA, Lindberg E (2015) Obstructive sleep apnea is a common disorder in the population \u2014 a review on the epidemiology of sleep apnea. J Thorac Dis 7(8):1311\u20131322. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2015.06.11","journal-title":"J Thorac Dis"},{"issue":"8","key":"2943_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2165\/00007256-200434080-00003","volume":"34","author":"F Hartgens","year":"2004","unstructured":"Hartgens F, Kuipers H (2004) Effects of androgenic anabolic steroids in athletes. Sports Med 34(8):513\u2013554. https:\/\/doi.org\/10.2165\/00007256-200434080-00003","journal-title":"Sports Med"},{"issue":"4","key":"2943_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1249\/01.mss.0000210194.56834.5d","volume":"38","author":"AB Parkinson","year":"2006","unstructured":"Parkinson AB, Evans NA (2006) Anabolic androgenic steroids: a survey in 500 users. Med Sci Sports Exerc 38(4):644\u2013651. https:\/\/doi.org\/10.1249\/01.mss.0000210194.56834.5d","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"2943_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00421-007-0621-6","volume":"102","author":"DP Venancio","year":"2008","unstructured":"Venancio DP, Tufik S, Garbuio SA, da Nobrega ACL, de Mello MT (2008) Effects of anabolic androgenic steroids on sleep patterns of individuals practicing resistance exercise. Eur J Appl Physiol 102(5):555\u2013560. https:\/\/doi.org\/10.1007\/s00421-007-0621-6","journal-title":"Eur J Appl Physiol"},{"issue":"2","key":"2943_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/ejendo\/lvag002","volume":"194","author":"TJ Verdegaal","year":"2026","unstructured":"Verdegaal TJ, de Ronde W, Jansen M, Bond P, Smit DL (2026) The efficacy of a harm reduction intervention for androgen abuse: a historically controlled trial. Eur J Endocrinol 194(2):69\u201379. https:\/\/doi.org\/10.1093\/ejendo\/lvag002","journal-title":"Eur J Endocrinol"},{"key":"2943_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.peh.2024.100288","volume":"12","author":"D Smit","year":"2024","unstructured":"Smit D, Verdegaal T, Bond P, Ronde W (2024) Navigating non-medical androgen use: towards a harm reduction paradigm. Perform Enhanc Health 12:1\u20135. https:\/\/doi.org\/10.1016\/j.peh.2024.100288","journal-title":"Perform Enhanc Health"},{"issue":"17","key":"2943_CR18","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1056\/NEJM199304293281704","volume":"328","author":"T Young","year":"1993","unstructured":"Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230\u20131235. https:\/\/doi.org\/10.1056\/NEJM199304293281704","journal-title":"N Engl J Med"},{"issue":"4","key":"2943_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.5664\/jcsm.8278","volume":"16","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Sowho M, Otvos T, Sperandio LS, East J, Sgambati F, Schwartz A, Schneider H (2020) A comparison of automated and manual sleep staging and respiratory event recognition in a portable sleep diagnostic device with in-lab sleep study. J Clin Sleep Med 16(4):563\u2013573. https:\/\/doi.org\/10.5664\/jcsm.8278","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"2943_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12888-024-05516-6","volume":"24","author":"S Klonteig","year":"2024","unstructured":"Klonteig S, Scarth M, Bj\u00f8rnebekk A (2024) Sleep pathology and use of anabolic androgen steroids among male weightlifters in Norway. BMC Psychiatr 24(1):62. https:\/\/doi.org\/10.1186\/s12888-024-05516-6","journal-title":"BMC Psychiatr"},{"key":"2943_CR21","doi-asserted-by":"publisher","unstructured":"Verdegaal TJ, Bond P, de Ronde W, Smit DL (2026) Effect of real-world androgen abuse on body composition: a prospective cohort study. J Clin Endocrinol Metab. Published online March 31, 2026. dgag142. https:\/\/doi.org\/10.1210\/clinem\/dgag142","DOI":"10.1210\/clinem\/dgag142"},{"issue":"2","key":"2943_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1113\/jphysiol.2004.071811","volume":"561","author":"JH Mateika","year":"2004","unstructured":"Mateika JH, Omran Q, Rowley JA, Zhou XS, Diamond MP, Badr MS (2004) Treatment with leuprolide acetate decreases the threshold of the ventilatory response to carbon dioxide in healthy males. J Physiol 561(2):637\u2013646. https:\/\/doi.org\/10.1113\/jphysiol.2004.071811","journal-title":"J Physiol"},{"key":"2943_CR23","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1210\/clinem\/dgaf635","volume":"111","author":"A Amodeo","year":"2026","unstructured":"Amodeo A, Cangiano B, Del Duca N, Chil\u00e0 A, Musolino A, Garavaglia I, Delle Donne E, Casiraghi A, Manzini C, Vezzoli V, Sola D, Gentile I, Palo A, Goggi G, Federici S, Persani L, Scacchi M, Bonomi M (2026) The role of obstructive sleep apnea and CPAP therapy in the functional hypogonadism of male patients with severe obesity. J Clin Endocrinol Metab 111:1272\u20131277. https:\/\/doi.org\/10.1210\/clinem\/dgaf635","journal-title":"J Clin Endocrinol Metab"},{"key":"2943_CR24","doi-asserted-by":"publisher","first-page":"1219239","DOI":"10.3389\/frph.2023.1219239","volume":"5","author":"A Graziani","year":"2023","unstructured":"Graziani A, Grande G, Ferlin A (2023) The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy. Front Reprod Health 5:1219239. https:\/\/doi.org\/10.3389\/frph.2023.1219239","journal-title":"Front Reprod Health"},{"key":"2943_CR25","doi-asserted-by":"publisher","first-page":"1148316","DOI":"10.3389\/frsle.2023.1148316","volume":"2","author":"CD Campbell","year":"2023","unstructured":"Campbell CD, Sulaiman I (2023) The role of the WatchPAT device in the diagnosis and management of obstructive sleep apnea. Front Sleep 2:1148316. https:\/\/doi.org\/10.3389\/frsle.2023.1148316","journal-title":"Front Sleep"},{"issue":"5","key":"2943_CR26","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2018-00229","volume":"103","author":"S Bhasin","year":"2018","unstructured":"Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA (2018) Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103(5):1715\u20131744. https:\/\/doi.org\/10.1210\/jc.2018-00229","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2943_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/sms.13592","volume":"30","author":"DL Smit","year":"2020","unstructured":"Smit DL, de Hon O, Venhuis BJ, den Heijer M, de Ronde W (2020) Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids. Scand J Med Sci Sports 30(3):531\u2013539. https:\/\/doi.org\/10.1111\/sms.13592","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"2943_CR28","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1186\/s12889-022-13734-4","volume":"22","author":"R Magnolini","year":"2022","unstructured":"Magnolini R, Falcato L, Cremonesi A, Schori D, Bruggmann P (2022) Fake anabolic androgenic steroids on the black market - a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature. BMC Public Health 22(1):1371. https:\/\/doi.org\/10.1186\/s12889-022-13734-4","journal-title":"BMC Public Health"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02943-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02943-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02943-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:34:11Z","timestamp":1790757251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02943-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2943"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02943-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study protocol and informed consent were approved by the local Medical Ethical Committee (METC Brabant, registration number P2117, study number NL77191.028.21) in June 2021 after which inclusion of participants was started.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T. Verdegaal, P. Bond and D. Smit are co-founders and shareholders of the Android Health Clinic. The other authors declare no conflict of interest related to this study.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}